5-Amino-1MQ
Preclinical Research5-Amino-1MQ
A small molecule NNMT inhibitor researched for fat loss, metabolic improvement, and potential anti-aging effects at the cellular level.
Dose
100-200 mg
Route
Oral
Cycle
Research protocols typically range from 8 to 12 weeks
Storage
5-Amino-1MQ is commonly supplied as a powder, often in capsules, for oral administration and is not typically supplied as a lyophilized powder for injection. As such, lyophilized storage instructions do not apply. The powder or encapsulated form should be stored at room temperature (20-25°C) away from light and moisture, with a shelf life typically specified by the manufacturer (often 2-3 years).
What is 5-Amino-1MQ?
5-Amino-1MQ is a research compound identified as a potent and selective inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme primarily found in adipose tissue and liver. By inhibiting NNMT, 5-Amino-1MQ aims to increase levels of S-adenosylmethionine (SAM) and NAD+ within cells, particularly adipocytes. This mechanism is theorized to promote fat cell metabolism, reduce fat accumulation, and potentially contribute to metabolic improvements. Research is largely preclinical, exploring its effects on obesity, metabolic dysfunction, and cellular aging pathways. It is commonly discussed for oral administration in research settings.
Key Benefits
- Fat cell shrinkage
- NNMT inhibition
- Metabolic improvement
- NAD+ pathway support
- Potential anti-aging effects
Mechanism of Action
- Inhibits nicotinamide N-methyltransferase (NNMT)
- Raises SAM levels in fat cells
- Activates fat cell metabolism
- Supports NAD+ availability
Best For
- Fat metabolism research
- Metabolic health
- Cellular aging research
Body Systems
🐾 Griffin Says...
Molecular Information
Molecular weight
163.2 g/mol
Type
Small Molecule, NNMT Inhibitor
Pharmacokinetics
Time to peak
Approximately 1-2 hours (oral administration)
Half-life
2.5 h
Time to clear
Elimination typically occurs within 12-24 hours
Based on preclinical pharmacokinetic data in animal models and extrapolation from studies on similar small molecules.
Research Indications
Fat Cell Shrinkage and Metabolism
Preclinical studies indicate 5-Amino-1MQ may reduce fat accumulation by inhibiting NNMT, thereby increasing SAM levels and promoting fat cell catabolism.
Obesity Research
In animal models, administration of 5-Amino-1MQ has been shown to reduce body weight and fat mass, particularly visceral fat, without calorie restriction.
Research Protocols
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| Investigating fat mass reduction in animal models | 2-10 mg/kg (oral gavage) | Once daily | Oral |
| Assessing metabolic improvements (e.g., glucose tolerance) | 100-200 mg | Once daily | Oral |
| Exploring NNMT inhibition kinetics in vitro | Variable, in nanomolar concentrations | Single application or continuous exposure | In vitro cell culture |
| Examining impact on hepatic steatosis in preclinical models | 5 mg/kg (oral gavage) | Once daily | Oral |
| Evaluating body composition changes | 150 mg | Once daily | Oral |
Oral administration typically involves taking the compound with water, independent of food, though some research discussions suggest taking it separate from large meals for optimal absorption.
Peptide Interactions
- Synergistic
Nicotinamide Riboside (NR) / Nicotinamide Mononucleotide (NMN)
Both aim to boost NAD+ levels; 5-Amino-1MQ does so by reducing NAD+ consumption via NNMT inhibition, while NR/NMN are direct precursors. The combination is theoretically synergistic, but research is limited.
- Monitor Combination
Metformin
Metformin affects glucose metabolism and AMPK activation. 5-Amino-1MQ also impacts metabolism. Combination studies are lacking, and careful monitoring of glucose levels and overall metabolic response is advised.
- Use Caution
Methylation Donors (e.g., TMG, SAMe)
5-Amino-1MQ's mechanism involves increasing SAM levels by inhibiting its consumption by NNMT. Combining with exogenous methylation donors could theoretically lead to excessive methylation, although specific interactions are not well-studied.
- Monitor Combination
Other Weight Loss Agents
Co-administration with other compounds intended for weight management (e.g., GLP-1 agonists, appetite suppressants) has not been studied. Potential for additive or unexpected effects on appetite, metabolism, and side effect profiles exists.
How to Reconstitute
- 1As 5-Amino-1MQ is commonly supplied as a powder for oral administration or in pre-dosed capsules, reconstitution for injection is not a standard research step. Researchers typically prepare oral solutions or use pre-encapsulated forms.
- 2If preparing an oral solution from powder: Accurately weigh the desired amount of 5-Amino-1MQ powder.
- 3Dissolve the powder in an appropriate solvent (e.g., distilled water, propylene glycol, or a mixture, depending on solubility and research needs) to achieve the target concentration.
- 4Mix thoroughly to ensure complete dissolution, typically by gentle swirling or stirring, avoiding vigorous shaking which can introduce air bubbles.
Since 5-Amino-1MQ is commonly supplied and used in powder or encapsulated form for oral administration in research, reconstitution with bacteriostatic water is not a standard protocol.
What to Expect
- Weeks 1-2: Some researchers report potential mild appetite modulation or subtle shifts in energy levels.
- Weeks 2-4: Early discussions suggest possible stabilization of energy and focus; some notice minor changes in body composition or visceral fat reduction.
- Weeks 4-8: More significant changes in body composition, particularly reductions in adipose tissue, may be observed in research subjects.
- Weeks 8-12: Peak effects on fat mass reduction and metabolic markers are often discussed, alongside sustained improvements in energy utilization.
- Beyond 12 weeks: Research on long-term effects is limited; continued observation for sustained benefits and potential adaptations is common practice.
Side Effects & Safety
| Effect | Frequency | Severity |
|---|---|---|
| Limited data available | Unknown | Unknown |
Ready to calculate your dose? Use Griffin's Peptide Calculator 🐾
Open CalculatorPeptides discussed here are for research purposes only. Nothing on this page is medical advice. Always consult a qualified professional before making health decisions.